Group 1 - The core point of the article is that Saito Bio has announced that its subsidiary, Shandong Sry Pharmaceutical Co., Ltd., has been re-certified as a high-tech enterprise, which will benefit the company with a reduced corporate income tax rate of 15% for three consecutive years starting from 2025 [2] Group 2 - The high-tech enterprise certificate is issued by multiple authorities including the Shandong Provincial Department of Science and Technology, the Shandong Provincial Department of Industry and Information Technology, the Shandong Provincial Department of Finance, and the State Taxation Administration of Shandong Province [2] - The certification is valid for three years, indicating the company's ongoing commitment to innovation and technology development [2] - This tax incentive is expected to enhance the company's financial performance and support its growth strategy in the pharmaceutical industry [2]
赛托生物:关于控股子公司再次获得高新技术企业证书的公告